Skip to main content
. 2021 Dec 14;116(4):201–219. doi: 10.1080/20477724.2021.2011579

Table 6.

Pooled prevalence of TB within population groups and across study covariates within minority indigenous populations

  Studies (n) Pooledα Prevalence TB (95% CI)
Study Population    
Minority indigenous populations 24 2.27 (1.69, 2.92)
Comparative Studies    
Non ‘minority indigenous’ populations 4 4.96 (0.32, 14.23)
Minority indigenous populations 4 5.04 (1.72, 9.93)
Analysis on indigenous populations only
WHO regions    
SEAR 18 2.23 (1.61, 2.95)
WPR 6 2.31 (0.65, 4.91)
WHO Mortality Strata    
A 2 1.93 (1.65, 2.23)
B 4 2.77 (0.08, 8.78)
D 18 2.23 (1.61, 2.95)
Countries    
Australia 2 1.93 (1.65, 2.23)
India 18 2.23 (1.61, 2.95)
Malaysia 3 2.87 (0.00, 11.99)
Solomon Islands 1 2.47 (1.62, 3.75)
Year of data collection    
1945–1970 4 2.46 (0.46, 5.95)
1971–1995 4 1.44 (0.81, 2.24)
1996–2020 16 2.44 (1.72, 3.28)
Age
<15 years
≥15 years
1
15
13.64 (7.34, 23.93)
2.40 (1.55, 3.41)
Sex
Female
Male
9 1.01 (0.53, 1.63)
2.89 (1.56, 4.59)
Diagnostic methods    
Clinical 7 2.05 (1.34, 2.89)
Culture 12 2.08 (1.28, 3.08)
Smear 8 2.18 (1.34, 3.22)
Screening Method    
Chest symptoms 16 1.76 (1.2, 2.41)
Mantoux skin test 2 1.93 (1.65, 2.23)
No pre-screening 4 6.86 (1.37, 15.91)
X-ray 2 0.37 (0.33, 0.42)

Note: α Prevalence pooled when >1 data set, otherwise result is presented from a single study